Natural Killer (NK) Cell Therapeutics Market Report

Europe Natural Killer (NK) Cell Therapeutics Market Size, Status and Forecast 2014-2026

  • POSTDATE：Mar 01, 2020
  • PAGES：170
  • REPORT CODE：GMM490557
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Natural Killer (NK) Cell Therapeutics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Natural Killer (NK) Cell Therapeutics Market Segmentations:

    By Player:

    • Takeda Pharmaceutical (Japan)

    • Altor BioScience Corporation (USA)

    • Affimed NV (Netherlands)

    • Innate Pharma SA (France)

    • Bristol-Myers Squibb (USA)

    • Chipscreen Biosciences (China)

    • NKT Therapeutics (USA)

    By Type:

    • Mogamulizumab

    • Lorvotuzumab Mertansine

    • Others

    By End-User:

    • Cancer

    • Cardiovascular Diseases

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Natural Killer (NK) Cell Therapeutics Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Mogamulizumab from 2014 to 2026

    • 1.3.2 Europe Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Lorvotuzumab Mertansine from 2014 to 2026

    • 1.3.3 Europe Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cancer from 2014 to 2026

    • 1.4.2 Europe Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026

    • 1.4.3 Europe Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Natural Killer (NK) Cell Therapeutics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Natural Killer (NK) Cell Therapeutics by Major Types

      • 3.4.1 Market Size and Growth Rate of Mogamulizumab

      • 3.4.2 Market Size and Growth Rate of Lorvotuzumab Mertansine

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Natural Killer (NK) Cell Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Natural Killer (NK) Cell Therapeutics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Natural Killer (NK) Cell Therapeutics for Cancer

      • 4.4.2 Market Size and Growth Rate of Natural Killer (NK) Cell Therapeutics for Cardiovascular Diseases

      • 4.4.3 Market Size and Growth Rate of Natural Killer (NK) Cell Therapeutics for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Natural Killer (NK) Cell Therapeutics Production Analysis by Top Regions

    • 5.2 Europe Natural Killer (NK) Cell Therapeutics Consumption Analysis by Top Regions

    • 5.3 Europe Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.3 France Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

    6 Product Circulation of Natural Killer (NK) Cell Therapeutics Market among Top Countries

    • 6.1 Top 5 Export Countries in Natural Killer (NK) Cell Therapeutics Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Natural Killer (NK) Cell Therapeutics Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Natural Killer (NK) Cell Therapeutics Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Natural Killer (NK) Cell Therapeutics Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Natural Killer (NK) Cell Therapeutics Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Natural Killer (NK) Cell Therapeutics Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 7.1 Germany Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 7.2 Germany Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    8. UK Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 8.1 UK Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 8.2 UK Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    9. France Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 9.1 France Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 9.2 France Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    10. Italy Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 10.1 Italy Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 10.2 Italy Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    11. Spain Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 11.1 Spain Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 11.2 Spain Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    12. Poland Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 12.1 Poland Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 12.2 Poland Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    13. Russia Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 13.1 Russia Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 13.2 Russia Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    14. Switzerland Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 14.1 Switzerland Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 14.2 Switzerland Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    15. Turkey Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 15.1 Turkey Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 15.2 Turkey Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Natural Killer (NK) Cell Therapeutics Landscape Analysis by Top Countries

      • 16.3.1 Denmark Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate

      • 16.3.2 Finland Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate

      • 16.3.3 Norway Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate

      • 16.3.4 Sweden Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate

      • 16.3.6 Iceland Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Natural Killer (NK) Cell Therapeutics Landscape Analysis by Top Countries

      • 17.3.1 Belgium Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate

      • 17.3.2 Netherlands Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate

      • 17.3.3 Luxembourg Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Natural Killer (NK) Cell Therapeutics Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Natural Killer (NK) Cell Therapeutics Landscape Analysis by Top Countries

      • 18.3.1 Estonia Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate

      • 18.3.2 Latvia Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate

      • 18.3.3 Lithuania Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Takeda Pharmaceutical (Japan)

      • 19.1.1 Takeda Pharmaceutical (Japan) Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Altor BioScience Corporation (USA)

      • 19.2.1 Altor BioScience Corporation (USA) Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Affimed NV (Netherlands)

      • 19.3.1 Affimed NV (Netherlands) Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Innate Pharma SA (France)

      • 19.4.1 Innate Pharma SA (France) Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Bristol-Myers Squibb (USA)

      • 19.5.1 Bristol-Myers Squibb (USA) Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Chipscreen Biosciences (China)

      • 19.6.1 Chipscreen Biosciences (China) Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 NKT Therapeutics (USA)

      • 19.7.1 NKT Therapeutics (USA) Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    The List of Tables and Figures (Totals 112 Figures and 158 Tables)

    • Figure Product Picture

    • Figure Europe Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Mogamulizumab from 2014 to 2026

    • Figure Europe Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Lorvotuzumab Mertansine from 2014 to 2026

    • Figure Europe Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cancer from 2014 to 2026

    • Figure Europe Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026

    • Figure Europe Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure UK Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure France Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Natural Killer (NK) Cell Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Natural Killer (NK) Cell Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Natural Killer (NK) Cell Therapeutics by Different Types from 2014 to 2026

    • Table Consumption Share of Natural Killer (NK) Cell Therapeutics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Mogamulizumab

    • Figure Market Size and Growth Rate of Lorvotuzumab Mertansine

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Natural Killer (NK) Cell Therapeutics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Natural Killer (NK) Cell Therapeutics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Cardiovascular Diseases

    • Figure Market Size and Growth Rate of Others

    • Table Europe Natural Killer (NK) Cell Therapeutics Production by Major Regions

    • Table Europe Natural Killer (NK) Cell Therapeutics Production Share by Major Regions

    • Figure Europe Natural Killer (NK) Cell Therapeutics Production Share by Major Countries and Regions in 2014

    • Table Europe Natural Killer (NK) Cell Therapeutics Consumption by Major Regions

    • Table Europe Natural Killer (NK) Cell Therapeutics Consumption Share by Major Regions

    • Table Germany Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

    • Table UK Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

    • Table France Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

    • Table Italy Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

    • Table Spain Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

    • Table Poland Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

    • Table Russia Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

    • Table Switzerland Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

    • Table Turkey Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Natural Killer (NK) Cell Therapeutics Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Natural Killer (NK) Cell Therapeutics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Natural Killer (NK) Cell Therapeutics Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Natural Killer (NK) Cell Therapeutics Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026

    • Table Germany Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Germany Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Germany Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table UK Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026

    • Table UK Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026

    • Table UK Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026

    • Table UK Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table France Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026

    • Table France Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026

    • Table France Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026

    • Table France Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Italy Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026

    • Table Italy Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Italy Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Italy Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Spain Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026

    • Table Spain Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Spain Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Spain Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Poland Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026

    • Table Poland Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Poland Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Poland Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Russia Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026

    • Table Russia Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Russia Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Russia Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026

    • Table Switzerland Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Switzerland Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Switzerland Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026

    • Table Turkey Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Turkey Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Turkey Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Natural Killer (NK) Cell Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Natural Killer (NK) Cell Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Natural Killer (NK) Cell Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Takeda Pharmaceutical (Japan)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical (Japan)

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical (Japan)

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical (Japan)

    • Table Product and Service Introduction of Takeda Pharmaceutical (Japan)

    • Table Company Profile and Development Status of Altor BioScience Corporation (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altor BioScience Corporation (USA)

    • Figure Sales and Growth Rate Analysis of Altor BioScience Corporation (USA)

    • Figure Revenue and Market Share Analysis of Altor BioScience Corporation (USA)

    • Table Product and Service Introduction of Altor BioScience Corporation (USA)

    • Table Company Profile and Development Status of Affimed NV (Netherlands)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Affimed NV (Netherlands)

    • Figure Sales and Growth Rate Analysis of Affimed NV (Netherlands)

    • Figure Revenue and Market Share Analysis of Affimed NV (Netherlands)

    • Table Product and Service Introduction of Affimed NV (Netherlands)

    • Table Company Profile and Development Status of Innate Pharma SA (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Innate Pharma SA (France)

    • Figure Sales and Growth Rate Analysis of Innate Pharma SA (France)

    • Figure Revenue and Market Share Analysis of Innate Pharma SA (France)

    • Table Product and Service Introduction of Innate Pharma SA (France)

    • Table Company Profile and Development Status of Bristol-Myers Squibb (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb (USA)

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb (USA)

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb (USA)

    • Table Product and Service Introduction of Bristol-Myers Squibb (USA)

    • Table Company Profile and Development Status of Chipscreen Biosciences (China)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chipscreen Biosciences (China)

    • Figure Sales and Growth Rate Analysis of Chipscreen Biosciences (China)

    • Figure Revenue and Market Share Analysis of Chipscreen Biosciences (China)

    • Table Product and Service Introduction of Chipscreen Biosciences (China)

    • Table Company Profile and Development Status of NKT Therapeutics (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NKT Therapeutics (USA)

    • Figure Sales and Growth Rate Analysis of NKT Therapeutics (USA)

    • Figure Revenue and Market Share Analysis of NKT Therapeutics (USA)

    • Table Product and Service Introduction of NKT Therapeutics (USA)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US